nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—Glucosamine—TNF—ankylosing spondylitis	0.0157	1	CrCbGaD
Azacitidine—DNMT3A—Amcinonide—Dexamethasone—ankylosing spondylitis	0.00627	0.0798	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Betamethasone—ankylosing spondylitis	0.00627	0.0798	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Triamcinolone—ankylosing spondylitis	0.00612	0.078	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Prednisone—ankylosing spondylitis	0.00581	0.074	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Prednisolone—ankylosing spondylitis	0.00567	0.0723	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Methylprednisolone—ankylosing spondylitis	0.00252	0.0321	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Dexamethasone—ankylosing spondylitis	0.00248	0.0316	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Betamethasone—ankylosing spondylitis	0.00248	0.0316	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Triamcinolone—ankylosing spondylitis	0.00242	0.0308	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Prednisone—ankylosing spondylitis	0.0023	0.0293	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Prednisolone—ankylosing spondylitis	0.00224	0.0286	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.00203	0.0259	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.00203	0.0259	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Dexamethasone—ankylosing spondylitis	0.002	0.0255	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Betamethasone—ankylosing spondylitis	0.002	0.0255	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00195	0.0249	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00195	0.0249	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Prednisone—ankylosing spondylitis	0.00185	0.0236	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Prednisone—ankylosing spondylitis	0.00185	0.0236	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00181	0.0231	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Prednisolone—ankylosing spondylitis	0.00181	0.0231	CbGdCrCtD
Azacitidine—Angiopathy—Prednisone—ankylosing spondylitis	0.00178	0.00197	CcSEcCtD
Azacitidine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00178	0.00196	CcSEcCtD
Azacitidine—Immune system disorder—Prednisone—ankylosing spondylitis	0.00178	0.00196	CcSEcCtD
Azacitidine—Malaise—Betamethasone—ankylosing spondylitis	0.00177	0.00196	CcSEcCtD
Azacitidine—Malaise—Dexamethasone—ankylosing spondylitis	0.00177	0.00196	CcSEcCtD
Azacitidine—Oedema—Triamcinolone—ankylosing spondylitis	0.00177	0.00195	CcSEcCtD
Azacitidine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00177	0.00195	CcSEcCtD
Azacitidine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00176	0.00195	CcSEcCtD
Azacitidine—Syncope—Dexamethasone—ankylosing spondylitis	0.00176	0.00195	CcSEcCtD
Azacitidine—Syncope—Betamethasone—ankylosing spondylitis	0.00176	0.00195	CcSEcCtD
Azacitidine—Infection—Triamcinolone—ankylosing spondylitis	0.00176	0.00194	CcSEcCtD
Azacitidine—Infection—Methylprednisolone—ankylosing spondylitis	0.00175	0.00194	CcSEcCtD
Azacitidine—Haematuria—Methotrexate—ankylosing spondylitis	0.00175	0.00193	CcSEcCtD
Azacitidine—Shock—Triamcinolone—ankylosing spondylitis	0.00174	0.00192	CcSEcCtD
Azacitidine—Insomnia—Prednisolone—ankylosing spondylitis	0.00174	0.00192	CcSEcCtD
Azacitidine—Alopecia—Prednisone—ankylosing spondylitis	0.00174	0.00192	CcSEcCtD
Azacitidine—Shock—Methylprednisolone—ankylosing spondylitis	0.00174	0.00192	CcSEcCtD
Azacitidine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00173	0.00191	CcSEcCtD
Azacitidine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00173	0.00191	CcSEcCtD
Azacitidine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00173	0.00191	CcSEcCtD
Azacitidine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00173	0.00191	CcSEcCtD
Azacitidine—Epistaxis—Methotrexate—ankylosing spondylitis	0.00173	0.00191	CcSEcCtD
Azacitidine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00173	0.00191	CcSEcCtD
Azacitidine—Mental disorder—Prednisone—ankylosing spondylitis	0.00172	0.0019	CcSEcCtD
Azacitidine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00172	0.0019	CcSEcCtD
Azacitidine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00171	0.00189	CcSEcCtD
Azacitidine—Malnutrition—Prednisone—ankylosing spondylitis	0.00171	0.00189	CcSEcCtD
Azacitidine—Erythema—Prednisone—ankylosing spondylitis	0.00171	0.00189	CcSEcCtD
Azacitidine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00171	0.00189	CcSEcCtD
Azacitidine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00171	0.00189	CcSEcCtD
Azacitidine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00171	0.00188	CcSEcCtD
Azacitidine—Convulsion—Betamethasone—ankylosing spondylitis	0.0017	0.00188	CcSEcCtD
Azacitidine—Convulsion—Dexamethasone—ankylosing spondylitis	0.0017	0.00188	CcSEcCtD
Azacitidine—Hypertension—Betamethasone—ankylosing spondylitis	0.0017	0.00187	CcSEcCtD
Azacitidine—Hypertension—Dexamethasone—ankylosing spondylitis	0.0017	0.00187	CcSEcCtD
Azacitidine—Myalgia—Betamethasone—ankylosing spondylitis	0.00167	0.00185	CcSEcCtD
Azacitidine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00167	0.00185	CcSEcCtD
Azacitidine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00167	0.00184	CcSEcCtD
Azacitidine—Anxiety—Betamethasone—ankylosing spondylitis	0.00167	0.00184	CcSEcCtD
Azacitidine—Discomfort—Dexamethasone—ankylosing spondylitis	0.00165	0.00183	CcSEcCtD
Azacitidine—Discomfort—Betamethasone—ankylosing spondylitis	0.00165	0.00183	CcSEcCtD
Azacitidine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00165	0.00182	CcSEcCtD
Azacitidine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00165	0.00182	CcSEcCtD
Azacitidine—Pain—Prednisolone—ankylosing spondylitis	0.00164	0.00182	CcSEcCtD
Azacitidine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00164	0.00182	CcSEcCtD
Azacitidine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00163	0.0018	CcSEcCtD
Azacitidine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00162	0.00179	CcSEcCtD
Azacitidine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00161	0.00178	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00161	0.00178	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00161	0.00178	CcSEcCtD
Azacitidine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.0016	0.00177	CcSEcCtD
Azacitidine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.0016	0.00177	CcSEcCtD
Azacitidine—Oedema—Dexamethasone—ankylosing spondylitis	0.0016	0.00177	CcSEcCtD
Azacitidine—Oedema—Betamethasone—ankylosing spondylitis	0.0016	0.00177	CcSEcCtD
Azacitidine—Insomnia—Triamcinolone—ankylosing spondylitis	0.0016	0.00177	CcSEcCtD
Azacitidine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.0016	0.00176	CcSEcCtD
Azacitidine—Infection—Betamethasone—ankylosing spondylitis	0.00159	0.00176	CcSEcCtD
Azacitidine—Infection—Dexamethasone—ankylosing spondylitis	0.00159	0.00176	CcSEcCtD
Azacitidine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00159	0.00175	CcSEcCtD
Azacitidine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00159	0.00175	CcSEcCtD
Azacitidine—Anaemia—Prednisone—ankylosing spondylitis	0.00158	0.00175	CcSEcCtD
Azacitidine—Shock—Betamethasone—ankylosing spondylitis	0.00158	0.00174	CcSEcCtD
Azacitidine—Shock—Dexamethasone—ankylosing spondylitis	0.00158	0.00174	CcSEcCtD
Azacitidine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00158	0.00174	CcSEcCtD
Azacitidine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00157	0.00174	CcSEcCtD
Azacitidine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00157	0.00174	CcSEcCtD
Azacitidine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00157	0.00173	CcSEcCtD
Azacitidine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00157	0.00173	CcSEcCtD
Azacitidine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00157	0.00173	CcSEcCtD
Azacitidine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00157	0.00173	CcSEcCtD
Azacitidine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00156	0.00172	CcSEcCtD
Azacitidine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00155	0.00172	CcSEcCtD
Azacitidine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00155	0.00171	CcSEcCtD
Azacitidine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00155	0.00171	CcSEcCtD
Azacitidine—Malaise—Prednisone—ankylosing spondylitis	0.00154	0.00171	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.00154	0.0196	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.00154	0.0196	CbGdCrCtD
Azacitidine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00154	0.0017	CcSEcCtD
Azacitidine—Syncope—Prednisone—ankylosing spondylitis	0.00154	0.0017	CcSEcCtD
Azacitidine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00153	0.00169	CcSEcCtD
Azacitidine—Anorexia—Betamethasone—ankylosing spondylitis	0.00153	0.00169	CcSEcCtD
Azacitidine—Urticaria—Prednisolone—ankylosing spondylitis	0.00153	0.00169	CcSEcCtD
Azacitidine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00153	0.00168	CcSEcCtD
Azacitidine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00152	0.00168	CcSEcCtD
Azacitidine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00152	0.00168	CcSEcCtD
Azacitidine—DNMT1—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00152	0.0193	CbGdCrCtD
Azacitidine—DNMT1—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00152	0.0193	CbGdCrCtD
Azacitidine—Pain—Triamcinolone—ankylosing spondylitis	0.00151	0.00167	CcSEcCtD
Azacitidine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00151	0.00166	CcSEcCtD
Azacitidine—Hypotension—Dexamethasone—ankylosing spondylitis	0.0015	0.00166	CcSEcCtD
Azacitidine—Hypotension—Betamethasone—ankylosing spondylitis	0.0015	0.00166	CcSEcCtD
Azacitidine—Angiopathy—Methotrexate—ankylosing spondylitis	0.00149	0.00165	CcSEcCtD
Azacitidine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00149	0.00164	CcSEcCtD
Azacitidine—Convulsion—Prednisone—ankylosing spondylitis	0.00148	0.00164	CcSEcCtD
Azacitidine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00148	0.00164	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00148	0.0189	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00148	0.0189	CbGdCrCtD
Azacitidine—Hypertension—Prednisone—ankylosing spondylitis	0.00148	0.00163	CcSEcCtD
Azacitidine—Chills—Methotrexate—ankylosing spondylitis	0.00148	0.00163	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00146	0.00161	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00146	0.00161	CcSEcCtD
Azacitidine—Myalgia—Prednisone—ankylosing spondylitis	0.00146	0.00161	CcSEcCtD
Azacitidine—Arthralgia—Prednisone—ankylosing spondylitis	0.00146	0.00161	CcSEcCtD
Azacitidine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00146	0.00161	CcSEcCtD
Azacitidine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00145	0.00161	CcSEcCtD
Azacitidine—Anxiety—Prednisone—ankylosing spondylitis	0.00145	0.0016	CcSEcCtD
Azacitidine—Alopecia—Methotrexate—ankylosing spondylitis	0.00145	0.0016	CcSEcCtD
Azacitidine—Insomnia—Betamethasone—ankylosing spondylitis	0.00145	0.0016	CcSEcCtD
Azacitidine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00145	0.0016	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00145	0.0016	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00144	0.00159	CcSEcCtD
Azacitidine—Discomfort—Prednisone—ankylosing spondylitis	0.00144	0.00159	CcSEcCtD
Azacitidine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00144	0.00159	CcSEcCtD
Azacitidine—Malnutrition—Methotrexate—ankylosing spondylitis	0.00143	0.00158	CcSEcCtD
Azacitidine—Erythema—Methotrexate—ankylosing spondylitis	0.00143	0.00158	CcSEcCtD
Azacitidine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00142	0.00156	CcSEcCtD
Azacitidine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00141	0.00156	CcSEcCtD
Azacitidine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00141	0.00156	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Prednisone—ankylosing spondylitis	0.00141	0.0179	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Prednisone—ankylosing spondylitis	0.00141	0.0179	CbGdCrCtD
Azacitidine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00141	0.00155	CcSEcCtD
Azacitidine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0014	0.00155	CcSEcCtD
Azacitidine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.0014	0.00154	CcSEcCtD
Azacitidine—Oedema—Prednisone—ankylosing spondylitis	0.0014	0.00154	CcSEcCtD
Azacitidine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.0014	0.00154	CcSEcCtD
Azacitidine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.0014	0.00154	CcSEcCtD
Azacitidine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.0014	0.00154	CcSEcCtD
Azacitidine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.0014	0.00154	CcSEcCtD
Azacitidine—Infection—Prednisone—ankylosing spondylitis	0.00139	0.00153	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00139	0.00153	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00139	0.00153	CcSEcCtD
Azacitidine—Back pain—Methotrexate—ankylosing spondylitis	0.00138	0.00153	CcSEcCtD
Azacitidine—Fatigue—Dexamethasone—ankylosing spondylitis	0.00138	0.00153	CcSEcCtD
Azacitidine—Fatigue—Betamethasone—ankylosing spondylitis	0.00138	0.00153	CcSEcCtD
Azacitidine—Shock—Prednisone—ankylosing spondylitis	0.00138	0.00152	CcSEcCtD
Azacitidine—Pain—Betamethasone—ankylosing spondylitis	0.00137	0.00152	CcSEcCtD
Azacitidine—Pain—Dexamethasone—ankylosing spondylitis	0.00137	0.00152	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Prednisolone—ankylosing spondylitis	0.00137	0.0175	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00137	0.0175	CbGdCrCtD
Azacitidine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00137	0.00151	CcSEcCtD
Azacitidine—Tachycardia—Prednisone—ankylosing spondylitis	0.00136	0.00151	CcSEcCtD
Azacitidine—Skin disorder—Prednisone—ankylosing spondylitis	0.00136	0.0015	CcSEcCtD
Azacitidine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00135	0.00149	CcSEcCtD
Azacitidine—Anorexia—Prednisone—ankylosing spondylitis	0.00133	0.00147	CcSEcCtD
Azacitidine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00133	0.00147	CcSEcCtD
Azacitidine—Anaemia—Methotrexate—ankylosing spondylitis	0.00132	0.00146	CcSEcCtD
Azacitidine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00132	0.00146	CcSEcCtD
Azacitidine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00132	0.00146	CcSEcCtD
Azacitidine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00131	0.00145	CcSEcCtD
Azacitidine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00131	0.00145	CcSEcCtD
Azacitidine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.0013	0.00144	CcSEcCtD
Azacitidine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.0013	0.00144	CcSEcCtD
Azacitidine—Malaise—Methotrexate—ankylosing spondylitis	0.00129	0.00142	CcSEcCtD
Azacitidine—Leukopenia—Methotrexate—ankylosing spondylitis	0.00128	0.00141	CcSEcCtD
Azacitidine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00128	0.00141	CcSEcCtD
Azacitidine—Urticaria—Betamethasone—ankylosing spondylitis	0.00128	0.00141	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00127	0.00141	CcSEcCtD
Azacitidine—Dizziness—Prednisolone—ankylosing spondylitis	0.00127	0.0014	CcSEcCtD
Azacitidine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00127	0.0014	CcSEcCtD
Azacitidine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00127	0.0014	CcSEcCtD
Azacitidine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00127	0.0014	CcSEcCtD
Azacitidine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00127	0.0014	CcSEcCtD
Azacitidine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00127	0.0014	CcSEcCtD
Azacitidine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00127	0.0014	CcSEcCtD
Azacitidine—Insomnia—Prednisone—ankylosing spondylitis	0.00126	0.0014	CcSEcCtD
Azacitidine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00125	0.00138	CcSEcCtD
Azacitidine—Cough—Methotrexate—ankylosing spondylitis	0.00125	0.00138	CcSEcCtD
Azacitidine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00125	0.00138	CcSEcCtD
Azacitidine—Convulsion—Methotrexate—ankylosing spondylitis	0.00124	0.00137	CcSEcCtD
Azacitidine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00123	0.00136	CcSEcCtD
Azacitidine—Chest pain—Methotrexate—ankylosing spondylitis	0.00122	0.00135	CcSEcCtD
Azacitidine—Myalgia—Methotrexate—ankylosing spondylitis	0.00122	0.00135	CcSEcCtD
Azacitidine—Arthralgia—Methotrexate—ankylosing spondylitis	0.00122	0.00135	CcSEcCtD
Azacitidine—Decreased appetite—Prednisone—ankylosing spondylitis	0.00122	0.00134	CcSEcCtD
Azacitidine—Rash—Prednisolone—ankylosing spondylitis	0.00121	0.00134	CcSEcCtD
Azacitidine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00121	0.00134	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00121	0.00134	CcSEcCtD
Azacitidine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00121	0.00133	CcSEcCtD
Azacitidine—Fatigue—Prednisone—ankylosing spondylitis	0.00121	0.00133	CcSEcCtD
Azacitidine—Headache—Prednisolone—ankylosing spondylitis	0.0012	0.00133	CcSEcCtD
Azacitidine—Discomfort—Methotrexate—ankylosing spondylitis	0.0012	0.00133	CcSEcCtD
Azacitidine—Constipation—Prednisone—ankylosing spondylitis	0.0012	0.00132	CcSEcCtD
Azacitidine—Confusional state—Methotrexate—ankylosing spondylitis	0.00118	0.0013	CcSEcCtD
Azacitidine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00117	0.00129	CcSEcCtD
Azacitidine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00117	0.00129	CcSEcCtD
Azacitidine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00117	0.00129	CcSEcCtD
Azacitidine—Infection—Methotrexate—ankylosing spondylitis	0.00116	0.00128	CcSEcCtD
Azacitidine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00115	0.00127	CcSEcCtD
Azacitidine—Asthenia—Betamethasone—ankylosing spondylitis	0.00115	0.00127	CcSEcCtD
Azacitidine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00115	0.00127	CcSEcCtD
Azacitidine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00115	0.00126	CcSEcCtD
Azacitidine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00114	0.00126	CcSEcCtD
Azacitidine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00114	0.00126	CcSEcCtD
Azacitidine—Nausea—Prednisolone—ankylosing spondylitis	0.00114	0.00126	CcSEcCtD
Azacitidine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00114	0.00125	CcSEcCtD
Azacitidine—Pruritus—Betamethasone—ankylosing spondylitis	0.00114	0.00125	CcSEcCtD
Azacitidine—Skin disorder—Methotrexate—ankylosing spondylitis	0.00113	0.00125	CcSEcCtD
Azacitidine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00113	0.00125	CcSEcCtD
Azacitidine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00112	0.00124	CcSEcCtD
Azacitidine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00112	0.00124	CcSEcCtD
Azacitidine—Rash—Triamcinolone—ankylosing spondylitis	0.00112	0.00123	CcSEcCtD
Azacitidine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00111	0.00123	CcSEcCtD
Azacitidine—Anorexia—Methotrexate—ankylosing spondylitis	0.00111	0.00123	CcSEcCtD
Azacitidine—Rash—Methylprednisolone—ankylosing spondylitis	0.00111	0.00123	CcSEcCtD
Azacitidine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00111	0.00123	CcSEcCtD
Azacitidine—Urticaria—Prednisone—ankylosing spondylitis	0.00111	0.00123	CcSEcCtD
Azacitidine—Headache—Triamcinolone—ankylosing spondylitis	0.00111	0.00122	CcSEcCtD
Azacitidine—Headache—Methylprednisolone—ankylosing spondylitis	0.00111	0.00122	CcSEcCtD
Azacitidine—Body temperature increased—Prednisone—ankylosing spondylitis	0.0011	0.00122	CcSEcCtD
Azacitidine—Abdominal pain—Prednisone—ankylosing spondylitis	0.0011	0.00122	CcSEcCtD
Azacitidine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.0011	0.00121	CcSEcCtD
Azacitidine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.0011	0.00121	CcSEcCtD
Azacitidine—Hypotension—Methotrexate—ankylosing spondylitis	0.00109	0.00121	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00106	0.00117	CcSEcCtD
Azacitidine—Dizziness—Betamethasone—ankylosing spondylitis	0.00106	0.00117	CcSEcCtD
Azacitidine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00106	0.00117	CcSEcCtD
Azacitidine—Insomnia—Methotrexate—ankylosing spondylitis	0.00106	0.00117	CcSEcCtD
Azacitidine—Nausea—Triamcinolone—ankylosing spondylitis	0.00105	0.00116	CcSEcCtD
Azacitidine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00105	0.00116	CcSEcCtD
Azacitidine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00104	0.00115	CcSEcCtD
Azacitidine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00103	0.00114	CcSEcCtD
Azacitidine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00103	0.00114	CcSEcCtD
Azacitidine—Vomiting—Betamethasone—ankylosing spondylitis	0.00102	0.00113	CcSEcCtD
Azacitidine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00102	0.00113	CcSEcCtD
Azacitidine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00102	0.00112	CcSEcCtD
Azacitidine—Rash—Dexamethasone—ankylosing spondylitis	0.00101	0.00112	CcSEcCtD
Azacitidine—Rash—Betamethasone—ankylosing spondylitis	0.00101	0.00112	CcSEcCtD
Azacitidine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00101	0.00112	CcSEcCtD
Azacitidine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00101	0.00112	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00101	0.00111	CcSEcCtD
Azacitidine—Fatigue—Methotrexate—ankylosing spondylitis	0.00101	0.00111	CcSEcCtD
Azacitidine—Headache—Betamethasone—ankylosing spondylitis	0.00101	0.00111	CcSEcCtD
Azacitidine—Headache—Dexamethasone—ankylosing spondylitis	0.00101	0.00111	CcSEcCtD
Azacitidine—Asthenia—Prednisone—ankylosing spondylitis	0.001	0.00111	CcSEcCtD
Azacitidine—Pain—Methotrexate—ankylosing spondylitis	0.000999	0.0011	CcSEcCtD
Azacitidine—Pruritus—Prednisone—ankylosing spondylitis	0.000989	0.00109	CcSEcCtD
Azacitidine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000963	0.00106	CcSEcCtD
Azacitidine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000956	0.00106	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000955	0.00105	CcSEcCtD
Azacitidine—Nausea—Dexamethasone—ankylosing spondylitis	0.000953	0.00105	CcSEcCtD
Azacitidine—Nausea—Betamethasone—ankylosing spondylitis	0.000953	0.00105	CcSEcCtD
Azacitidine—Urticaria—Methotrexate—ankylosing spondylitis	0.000928	0.00102	CcSEcCtD
Azacitidine—Dizziness—Prednisone—ankylosing spondylitis	0.000924	0.00102	CcSEcCtD
Azacitidine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000923	0.00102	CcSEcCtD
Azacitidine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000923	0.00102	CcSEcCtD
Azacitidine—Vomiting—Prednisone—ankylosing spondylitis	0.000889	0.000981	CcSEcCtD
Azacitidine—Rash—Prednisone—ankylosing spondylitis	0.000881	0.000973	CcSEcCtD
Azacitidine—Dermatitis—Prednisone—ankylosing spondylitis	0.00088	0.000972	CcSEcCtD
Azacitidine—Headache—Prednisone—ankylosing spondylitis	0.000876	0.000967	CcSEcCtD
Azacitidine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000861	0.00095	CcSEcCtD
Azacitidine—Asthenia—Methotrexate—ankylosing spondylitis	0.000838	0.000925	CcSEcCtD
Azacitidine—Nausea—Prednisone—ankylosing spondylitis	0.00083	0.000917	CcSEcCtD
Azacitidine—Pruritus—Methotrexate—ankylosing spondylitis	0.000826	0.000912	CcSEcCtD
Azacitidine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000799	0.000882	CcSEcCtD
Azacitidine—Dizziness—Methotrexate—ankylosing spondylitis	0.000772	0.000853	CcSEcCtD
Azacitidine—Vomiting—Methotrexate—ankylosing spondylitis	0.000743	0.00082	CcSEcCtD
Azacitidine—Rash—Methotrexate—ankylosing spondylitis	0.000737	0.000813	CcSEcCtD
Azacitidine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000736	0.000812	CcSEcCtD
Azacitidine—Headache—Methotrexate—ankylosing spondylitis	0.000732	0.000808	CcSEcCtD
Azacitidine—Nausea—Methotrexate—ankylosing spondylitis	0.000694	0.000766	CcSEcCtD
